Boehringer Ingelheim and BioMed X start new project to explore and develop unprecedented new treatme

Boehringer Ingelheim and BioMed X announced today that they have established a new research team of outstanding scientists from around the world that will conduct research to identify novel approaches for the treatment of patients with psychiatric diseases. The members of this team had submitted the most promising solution approaches in a crowdsourcing competition.

Click on this link for more information.